Weight loss decreases follicle stimulating hormone in overweight postmenopausal women

Obesity

Volumn 23, Issue 1, 2015, Pages 228-233

  Kim, Catherine ^a   Randolph, John F ^a   Golden, Sherita H ^b   Labrie, Fernand ^c   Kong, Shengchun ^d   Nan, Bin ^d   Barrett Connor, Elizabeth ^e  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITÉ LAVAL   (Canada)

^d PURDUE UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; FOLLITROPIN; METFORMIN; PLACEBO; ESTRADIOL;

ADULT; AFRICAN AMERICAN; ALCOHOL CONSUMPTION; ANALYSIS OF VARIANCE; ARTICLE; ASIAN; BODY MASS; CAUCASIAN; CONTROLLED STUDY; ESTROGEN BLOOD LEVEL; ETHNICITY; EXERCISE INTENSITY; FEMALE; FOLLITROPIN BLOOD LEVEL; FOOD INTAKE; GAS CHROMATOGRAPHY; GLUCOSE INTOLERANCE; HISPANIC; HUMAN; HYSTERECTOMY; LEISURE; LIFESTYLE MODIFICATION; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; OBESITY; PHYSICAL ACTIVITY; POSTMENOPAUSE; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; AGED; BEHAVIOR THERAPY; BLOOD; BODY WEIGHT; CLINICAL TRIAL; COMPLICATION; DIABETES MELLITUS, TYPE 2; LIFESTYLE; MIDDLE AGED; MULTICENTER STUDY; OVERWEIGHT; PHYSIOLOGY;

AGED; BEHAVIOR THERAPY; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LIFE STYLE; METFORMIN; MIDDLE AGED; OVERWEIGHT; POSTMENOPAUSE; WEIGHT LOSS;

EID: 84928269905     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20917     Document Type: Article

References (29)

1. Freeman E, Sammel M, Lin H, Gracia C,. Obesity and reproductive hormone levels in the transition to menopause. Menopause 2010; 17: 718-726.
2. Tepper P, Randolph J, McConnell D, et al. Trajectory clustering of estradiol and follicle-stimulating hormone during the menopausal transition among women in the Study of Women's Health Across the Nation. J Clin Endocrinol Metab 2012; 97: 2872-2880.
3. Endogenous Hormones Breast Cancer Collaborative Group. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 2003; 95: 1218-1226.
4. Karim R, Mack W, Hodis H, Roy S, Stanczyk F,. Influence of age and obesity on serum estradiol, estrone, and sex hormone binding globulin concentrations following oral estrogen administration in postmenopausal women. J Clin Endocrinol Metab 2009; 94: 4136-4143.
5. Lambrinoudaki I, Armeni E, Rizos D, et al. Sex hormones in postmenopausal women receiving low-dose hormone therapy: the effect of BMI. Obesity (Silver Spring) 2011; 19: 988-993.
6. Waaseth M, Bakken K, Dumeaux V, et al. Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer Postgenome Cohort-a cross-sectional analysis. BMC Women's Health 2008; 1, doi: 10.1186/1472-6874-8-1.
7. Pasquali R,. Obesity and androgens: facts and perspectives. Fertil Steril 2006; 85: 1319-1340.
8. Flegal K, Carroll M, Kit B, Ogden C,. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012; 307: 491-497.
9. Wildman R, Tepper P, Crawford S, et al. Do changes in sex steroid hormones precede or follow increases in body weight during the menopause transition? Results from the Study of Women's Health Across the Nation. J Clin Endocrinol Metab 2012; 97: 1695-1704.
10. De Pergola G, Maldera S, Tartagni M, Pannacciulli N, Loverro G, Giorgino R,. Inhibitory effect of obesity on gonadotropin, estradiol, and inhibin B levels in fertile women. Obesity (Silver Spring) 2006; 14: 1954-1960.
11. Kim C, Nan B, Laughlin G, et al. Endogenous sex hormone changes in postmenopausal women in the Diabetes Prevention Program. J Clin Endocrinol Metab 2012; 97: 2853-2861.
12. Golden S, Dobs A, Vaidya D, et al. Endogenous sex hormones and glucose tolerance status in postmenopausal women. J Clin Endocrinol Metab 2007; 92: 1289-1295.
13. Ding E, Song Y, Malik V, Liu S,. Sex differences of endogenous sex hormones and risk of type 2 diabetes. JAMA 2006; 295: 1288-1299.
14. Ding E, Song Y, Manson J, Rifai N, Buring J, Liu S,. Plasma sex steroid hormones and risk of developing type 2 diabetes in women: A prospective study. Diabetologia 2007; 50: 2076-2084.
15. Knowler W, Barrett-Connor E, Fowler S, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
16. Mayer-Davis E, Vitolins M, Carmiachael S, et al. Validity and reproducibility of a food frequency interview in a multi-cultural epidemiology study. Ann Epidemiol 1999; 9: 314-324.
17. Kriska A, Caspersen C,. Introduction to the collection of physical activity questionnaires. Med Sci Sports Exerc 1997; 29: 5-9.
18. Sodergard R, Backstrom T, Shanbhag V, Carstensen H,. Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem 1982; 16: 801-810.
19. Kim C, Golden S, Mather K, et al. Racial/ethnic differences in sex hormone levels among postmenopausal women in the Diabetes Prevention Program. J Clin Endocrinol Metab 2012; 97: 4051-4060.
20. Grenman S, Ronnemaa T, Iriala K, Kaihola H, Gronroos M,. Sex steroid, gonadotropin, cortisol, and prolactin levels in healthy, massively obese women: correlation with abdominal fat cell size and effect of weight reduction. J Clin Endocrinol Metab 1986; 63: 1257-1261.
21. Campbell K, Foster-Schubert K, Alfano C, et al. Reduced-calorie dietary weight loss, exercise, and sex hormones in postmenopausal women: randomized controlled trial. J Clin Oncol 2012; 30: 2314-2326.
22. Wu A, Pike M, Stram D,. Meta-analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer. J Natl Cancer Inst 1999; 91: 529-534.
23. McTiernan A, Tworoger S, Ulrich C, et al. Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial. Cancer Res 2004; 64: 2923-2928.
24. Liedtke S, Schmidt M, Vrieling A, et al. Postmenopausal sex hormones in relation to body fat distribution. Obesity (Silver Spring) 2012; 20: 1088-1095.
25. Sowers M, Eyvazzadeh A, McConnell D, et al. Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab 2008; 93: 3478-3483.
26. Sowers M, McConnell D, Yosef M, Jannausch M, Harlow S, Randolph J Jr,. Relating smoking, obesity, insulin resistance, and ovarian biomarker changes to the final menstrual period. Ann N Y Acad Sci 2010; 1204: 95-103.
27. Gracia C, Freeman E, Sammel M, Lin H, Nelson D,. The relationship between obesity and race on inhibin B during the menopause tradition. Menopause 2005; 12: 559-566.
28. Sowers M, Wildman R, Mancuso P, et al. Change in adipocytokines and ghrelin with menopause. Maturitas 2008; 59: 149-157.
29. Garin M, Burns C, Kaul S, Cappola A,. Clinical review: the human experience with ghrelin administration. J Clin Endocrinol Metab 2013; 98: 1826-1837.